How much funding has Mirvie raised?

Mirvie has raised $118.3M in total funding, most recently a Venture Round.

Who are Mirvie's investors?

Mirvie's investors include BlackRock, Decheng Capital, Foresite Capital, Khosla Ventures, Bill & Melinda Gates Foundation, Mayfield Fund.

Where is Mirvie headquartered?

Mirvie is headquartered in San Francisco Bay Area, California, United States.

What industry is Mirvie in?

Mirvie operates in Life Sciences, Biotech, Healthcare.

Mirvie

A personalized window into pregnancy health

San Francisco Bay Area, United States · Founded 2018 · $118.3M raised

Life Sciences

Biotech

Healthcare

Headquarters: San Francisco Bay Area, California
Employees: 11–50
Founded: 2018
Website: mirvie.com

Total Funding: $118.3M
Last Round: $23.7M Venture RoundAug 2025
Rounds: 4

About

Mirvie is a women's health company that has developed a proprietary RNA platform to predict pregnancy complications months before symptoms appear using a simple blood draw. The platform analyzes tens of thousands of RNA messages from the baby, placenta, and mother, combining them with machine learning to identify risk for conditions like preeclampsia and preterm birth. Its Encompass test for preeclampsia received clinical validation in studies published in Nature and other peer-reviewed journals.

Summary

Mirvie is a Life Sciences company based in San Francisco Bay Area, United States, founded in 2018. It has raised $118.3M in total across 4 rounds, most recently a $23.7M Venture Round round in Aug 2025. Investors include BlackRock, Decheng Capital and Foresite Capital.

LinkedIn X (Twitter)